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Abstract
Background: Dietary polyunsaturated fatty acids (PUFA), in particular the long chain marine fatty
acids docosahexaenoic (DHA) and eicosapentaenoic (EPA), are linked to many health benefits in
humans and in animal models. Little is known of the molecular response to DHA and EPA of the
small intestine, and the potential contribution of this organ to the beneficial effects of these fatty
acids. Here, we assessed gene expression changes induced by DHA and EPA in the wildtype C57BL/
6J murine small intestine using whole genome microarrays and functionally characterized the most
prominent biological process.
Results:  The main biological process affected based on gene expression analysis was lipid
metabolism. Fatty acid uptake, peroxisomal and mitochondrial beta-oxidation, and omega-
oxidation of fatty acids were all increased. Quantitative real time PCR, and -in a second animal
experiment- intestinal fatty acid oxidation measurements confirmed significant gene expression
differences and showed in a dose-dependent manner significant changes at biological functional
level. Furthermore, no major changes in the expression of lipid metabolism genes were observed
in the colon.
Conclusion: We show that marine n-3 fatty acids regulate small intestinal gene expression and
increase fatty acid oxidation. Since this organ contributes significantly to whole organism energy
use, this effect on the small intestine may well contribute to the beneficial physiological effects of
marine PUFAs under conditions that will normally lead to development of obesity, insulin
resistance and diabetes.
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Background
Diets rich in polyunsaturated fatty acids (PUFA) of n-3
series show many beneficial health effects, both in animal
models and humans. These include effects on cardiovas-
cular and immune systems, on glucose homeostasis, as
well as on the accumulation of body fat (e.g. reviewed by
[1-3]). However, recent epidemiological studies started a
debate on the possible health benefits of n-3 PUFA [4,5].
To resolve the potential health benefits of these fatty acids,
knowledge of the underlying mechanisms is needed.
To elucidate molecular effects of n-3 PUFA in vivo, gene
expression analyses have been undertaken in animal
models using a variety of dietary fatty acids in several tis-
sues, including brain, liver, heart, and adipose [6-16]. The
majority of those studies focused on liver and white adi-
pose tissue (WAT), which is not surprising given the fact
that these are considered the main target organs in a die-
tary intervention with fatty acids. Since the intestine con-
tributes to a significant extend to the resting metabolic
rate and daily energy expenditure [17], it is of relevance to
also understand the effects on this organ. Recent studies
[18,19] also showed a clear and significant difference of
intestinal gene expression between diets high in diacylg-
lycerol versus triacylglycerol, indicating a profound con-
tribution of the small intestine to fatty acid metabolism.
Moreover, induction of lipid catabolism genes in the
intestine may be involved in the anti-obesity effect of dia-
cylglycerols as compared with triacylglycerols [18,19] and
it may even contribute to a differential sensitivity of two
inbred mice strains to an obesogenic high-fat diet [20].
Since the most prominent health benefits have been asso-
ciated with the long-chain n-3 PUFA of marine origin (for
references see [21,22]), we have investigated the molecu-
lar effects of eicosapentaenoic acid (EPA; 20:5 n-3) and
docosahexaenoic acid (DHA; 22:6 n-3) in n-3 high-fat
diets. These diets, which do not differ in the total amount
of fat relative to control, will be further referred to as
EPA&DHA. In our previous studies using similar diets, we
showed an anti-adipogenic effect of EPA&DHA [8,23],
which was associated with induction of mitochondrial
biogenesis and beta-oxidation of fatty acids in WAT, but
not in the liver [8].
We hypothesized that, using long-term dietary interven-
tion studies, dietary fatty acid composition may modulate
gene expression and lipid metabolism in the intestine,
and that especially EPA and DHA may stimulate expres-
sion of genes involved in lipid catabolism. To examine
this, we performed gene expression analysis of the mouse
small intestine and colon, using whole genome oligonu-
cleotide arrays and validation experiments using quantita-
tive real time PCR (qRT-PCR). Results were confirmed in
an additional animal experiment by both qRT-PCR and
functional intestinal fatty acid beta oxidation measure-
ments.
Results
Phenotypic effects of EPA&DHA
Dietary intervention with EPA&DHA in wildtype mice
resulted in anti-adipogenic and anti-diabetic effects as
described before: significantly lower body weight and
epididymal adipose tissue weight, while food intake was
non-significantly different [8,23]. Furthermore, the intake
of EPA&DHA increased adiponectin expression and secre-
tion from WAT, and protected the mice against induction
of insulin resistance by the high-fat diet [23]. Indeed, glu-
cose tolerance tests showed significantly increased glucose
tolerance (decreased area under the curves) by increasing
amounts of EPA&DHA in the diets, correlating with
decreased fasting plasma insulin levels (data not shown).
This was associated with induction of mitochondrial bio-
genesis and beta-oxidation of fatty acids in WAT based on
gene and protein expression, but not in the liver [8]. How-
ever, the role of the intestine in the improved whole-body
metabolic phenotype has not yet been analysed in detail.
Effects of EPA&DHA on small intestinal gene expression; 
analysis of genes expressed in both control and 
intervention group
To investigate the effects of EPA&DHA on gene expression
in the intestinal tract, we isolated RNA from scrapings
from small intestine of mice following a 4-week dietary
intervention. We compared, using whole genome micro-
array analysis as initial step, the control sHF diet, which
was rich in ALA and free of EPA or DHA, with the isoca-
loric sHFf-F2 diet, in which 44% of lipids were replaced by
an EPA and DHA concentrate.
In total, 155 probesets, corresponding to 134 well-anno-
tated genes, showed a significant regulation with an abso-
lute fold change (FC) ≥ 2.0 [see Additional file 1]. This list
of 134 genes comprised 110 unique genes, and increased
expression was observed for 80 (102 probesets) unique
genes, while 30 (32 probesets) unique genes showed
decreased expression (Table 1). Functional interpretation
using gene ontology and pathway analysis showed metab-
olism as highly regulated, which included changes in fatty
acid uptake, fatty acid oxidation and cholesterol biosyn-
thesis, amongst others. Of note, most, if not all, pathways
selected were linked together by the energy molecule
acetyl-CoA. The approach using a FC ≥ 1.5 as threshold
resulted in a similar list of regulated pathways, of which
metabolism, and especially lipid metabolism ranked
highest (a more detailed description of these approaches
and detailed results are described additionally [see Addi-
tional file 2]). Since it is known that a dietary intervention
at physiological levels generally gives small effects on gene
expression changes ([24,25], own unpublished observa-BMC Genomics 2009, 10:110 http://www.biomedcentral.com/1471-2164/10/110
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tions), and the sufficiently large group of genes with FC ≥
2.0, we focussed on those 100 unique, differentially
expressed genes (see Table 1).
Detailed inspection of the expression data ([see Addi-
tional file 1]; see also for full names of the genes) revealed
that EPA&DHA induced expression of the genes involved
in branched chain and/or straight chain fatty acid β-oxida-
tion occurring in peroxisomes and mitochondria, and
fatty acid ω-oxidation, the latter is indicated by the
increased expression of Cyp4a10 (FC = 5.6). Furthermore,
induction of the peroxisomal biogenesis factor gene
Pex11a (FC = 2.2) might imply an increase in the number
of peroxisomes.
In mitochondria, β-oxidation downstream of peroxiso-
mal branched chain oxidation was upregulated by
EPA&DHA, as suggested by increased expression of the
genes CPT1a (FC = 2.9), and Hadhb (FC = 2.2) amongst
others. Activity of carnitine palmitoyltransferase 1
(encoded by Cpt1a) is rate-limiting in mitochondrial fatty
acid uptake for β-oxidation. The gene encoding 3-
hydroxy-3-methyglutaryl-CoA synthase (Hmgcs2) was
also very strongly upregulated (FC = 4.6), in accordance
with the fact that in liver this enzyme is the rate limiting
enzyme in the synthesis of ketone bodies from the acetyl-
CoA generated by fatty acid β-oxidation. Importantly, also
expression of Pdk4  was increased by EPA&DHA (FC =
3.0), which strongly suggested a switch from glycolysis to
fatty acid oxidation [26]. Many of the aforementioned
genes are targets of peroxisome proliferator activated
receptor (PPAR) alpha [27,28], which itself was also
upregulated by EPA&DHA (FC = 2.0).
Cholesterol uptake from the lumen into intestinal tissue
was increased as observed by increased gene expression of
Cd36 (FC = 2.3) and Scarb1 (FC = 2.2) [29]. Simultane-
ously, of the 21 genes included in the cholesterol biosyn-
thesis pathway from acetyl-CoA to cholesterol, 2 were not
expressed, while the majority showed an inhibition by
EPA&DHA, including the rate-limiting enzyme squalene
epoxidase (Sqle, FC = -2.1). Clearly, such a cooperative
inhibition of the majority of the genes in this pathway
suggests an orchestrated function within the small intes-
tine. However, the main transcription factor regulating
this pathway, Srebf1 (SREBP), did not show differential
expression. Regulation by n-3 PUFAs was likely given the
fact that we could not detect a difference in the cholesterol
content between the two diets (data not shown), but the
exact mechanisms involved remain unexplained. Finally,
downstream steroid hormone biosynthesis was upregu-
lated as shown by a few family members of Hsd3b
(Hsd3b2: FC = 2.3; Hsd3b3 FC = 2.0) and Hsd17b (Hsd17b4
two probesets: FC = 1.6 and 2.0; Hsd17b13 FC = 2.4).
Transcription factor identification by promoter analysis
Literature data and annotation analysis was used to filter
the set of regulated genes (see Methods). From the result-
ing 50 unique genes the promoter region was retrieved,
which was used for enrichment analysis of transcription
factor binding sites (TFBS). This resulted in a network of
47 genes and linked transcription factors (TFs) that com-
prised 42 unique input genes, including two TFs (PPARal-
pha and Dbp), and another 5 non-regulated TFs (NF-κB,
Stat3, Sp1, Ahr, and Arnt1; [see Additional file 3]). The
majority of differentially regulated genes contained bind-
ing sites for two transcription factors: PPARalpha (27
genes), which itself was significantly differentially regu-
lated (see above), and NF-κB (20 genes). These data are in
line with the well-known capacity of fatty acids to activate
PPARalpha [30], as well as their known effects on NF-κB
and Stat3 [3,31].
Table 1: Differentially expressed, unique genes classified in biological processes.
Process Upregulated Downregulated Total
Metabolism 40 9 49
Transport 4 3 7
Apoptosis/cell cycle 4 2 6
Cell adhesion/homeostasis/structure 4 1 5
Digestion 4 0 4
Immune system 1 3 4
Hemopoiesis 1 2 3
Transcription/translation 3 0 3
Signal transduction 2 0 2
Steroid hormone metabolism 2 0 2
Miscellaneous/unknown 8 7 15
Total: 73 27 100
Unique genes (expressed in both dietary groups, FC ≥ 2.0) are classified in 11 processes, and ranked on total number of genes per process. Number 
of genes upregulated or downregulated by EPA&DHA in small intestine is as indicated.BMC Genomics 2009, 10:110 http://www.biomedcentral.com/1471-2164/10/110
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Effects of EPA&DHA on small intestinal gene expression; 
analysis of genes expressed exclusively in either control or 
intervention group
In addition to the genes that showed expression above the
threshold in both groups, we also analysed the 159
probesets being expressed in only one diet group and
showing differential expression. We focused on those
genes showing a FC ≥ 2.0. In this way, fidelity of the data-
set is within acceptable limits as most of these genes are
expressed at low abundance. This resulted in 23 unique
genes expressed only in the mice fed the EPA&DHA diet,
while 47 unique genes showed only expression in the con-
trol group. All genes were classified into biological proc-
esses (Table 2, [see Additional file 4]), which largely
overlapped with the pathways identified using the first
subset. Of note, metabolism was also ranked highest,
among which are the lipid metabolism genes acetyl-Coen-
zyme A carboxylase-β (Acacb), Cpa2, and the peroxisomal
protein encoded by Acot3, which all showed an induction
from being absent in the control group to clear expression
in EPA&DHA dietary group.
Inter-individual variation analysis and confirmation by real 
time qRT-PCR
Confirmation of differentially expressed genes was first
performed using qRT-PCR. We selected a large panel of
target genes covering multiple pathways and absolute FC
values ranging from 1.3 to > 4. Expression changes (up- or
downregulation) were confirmed for all genes (Table 3)
and the FC was quite similar in all cases when compared
to the microarray data.
To investigate in more detail inter-individual variation in
gene expression and significance of the induced gene
expression changes by nutritional treatment, we selected
the following 6 genes representing the major pathways
being influenced by the diet intervention (see above):
fatty acid β-oxidation in peroxisomes (Acaa1a) and mito-
chondria (Cpt1a and Acacb), the switch between glycolysis
and fatty acid oxidation (Pdk4), biosynthesis of steroid
hormones (Hsd3b), and biosynthesis of cholesterol (Sqle).
For all genes we observed that the mean gene expression
ratios (n = 10–11 per dietary group) were similar to the
observed ratios by microarray analysis of pooled samples.
More importantly, gene expression changes using individ-
ual samples were statistically significant for all genes (Fig-
ure 1, Table 3).
Colon
The genes Acaa1a,  Cpt1a, and Sqle, representing three
pathways differentially regulated in small intestine, were
analyzed by qRT-PCR in individual colon samples (n =
10). In none of the cases a significant difference in gene
expression was observed (Figure 2). Exclusion of the two
animals from the control group which showed lowest
expression for these three genes (10-fold or more) did not
influence the outcome of this analysis (maximum FC <
1.15, all non-significant; data not shown). This under-
scores the different function of the small intestine (mainly
uptake and transfer of nutrients) and the colon (mainly
water absorption).
Biological and physiological validation in 2nd animal 
experiment
To further validate the observed significant gene expres-
sion changes, we performed an independent second ani-
mal experiment and analysed small intestinal gene
expression by qRT-PCR. Moreover, the increased gene
expression suggesting increased intestinal fatty acid beta
oxidation was functionally analysed, and finally, we used
two EPA&DHA diets in order to investigate a dose-
response relationship. In this experiment, cHF-based diets
were used. Although the micronutrient composition of
the control cHF diet is not defined as precisely as the sem-
isynthetic sHFf diet used in the first experiment, and it is
based on (n-6 PUFA rich) corn oil rather than on (ALA-
Table 2: Differentially expressed genes with exclusive expression in only EPA&DHA or control dietary group.
Process Expressed in EPA & DHA diet Expressed in control diet Total
Metabolism 11 4 15
Transcription/translation/splicing 3 6 9
Cell adhesion/proliferation/differentiation/structure - 7 7
Signal transduction - 7 7
Transport 1 5 6
Protein folding/modification 1 4 5
Cell cycle 1 1 2
Growth factor 1 1 2
Miscellaneous/unknown 5 12 17
Total: 23 47 70
Annotated, unique genes (FC ≥ 2) were classified in biological processes. Processes were ranked on total number of genes being differentially 
expressed in small intestine.BMC Genomics 2009, 10:110 http://www.biomedcentral.com/1471-2164/10/110
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rich) flaxseed, the control cHF diet promotes accumula-
tion of fat much better compared with the sHFf diet and
hence it allows for the detection of the anti-obesity effect
of n-3 PUFA [22]. In addition to the control cHF diet, also
two other cHF-based diets with 15 and 44% of its lipids
replaced by EPA&DHA (cHF-F1 and cHF-F2, respectively)
were used. Gene expression analysis of genes involved in
mitochondrial beta oxidation (Cpt1a  and  Acacb) inde-
pendently and significantly confirmed the observed sig-
nificant differences (Figure 3a,b). Moreover, these results
showed a significant dose-response effect: increased gene
expression upon increased EPA&DHA content in the diets
(Figure 3a,b). Furthermore, functional analysis indeed
showed a significant dose-dependent increase in intesti-
nal fatty acid beta oxidation upon increased EPA&DHA
content in the diet compared to control diet: lowest levels
in the control group, intermediate increased levels in the
cHF-F1 group and highest levels in the cHF-F2 group (Fig-
ure 3c).
Discussion
Dietary intake of EPA&DHA induced changes in gene
expression in the small intestine, including many meta-
bolic genes. Especially genes involved in lipid catabolism
were upregulated. In contrast, a large cluster of the genes
engaged in cholesterol biosynthesis was downregulated.
Importantly, all these effects were specifically induced by
long-chain n-3 PUFA, EPA and DHA, as compared with
their precursor ALA, and could not be detected in the
colon for a selected set of genes.
It is tempting to suggest that increased catabolism of lip-
ids induced by EPA&DHA in the small intestine contrib-
utes to the complex and beneficial effects of n-3 PUFA of
Table 3: Microarray data validation by qRT-PCR
Microarray ratio qRT-PCR ratio
Genes Probeset ID Pool Pool mean ratio (n = 10–11)
Acaa1a 1456011_x_at 1.67 2.00 2.52 *
Acaa1b 1424451_at 2.19 1.75
Acaa1a/Acaa1b 1416946_a_at 1.87
1416947_s_at 1.59
Acacb 1427052_at 6.9 a n.d.c 3.91 *
Acox1 1416409_at 1.24 1.34
1416408_at 1.35
Acox2 1420673_a_at 2.91 1.97
Acox3 1420684_at n.c.b -1.23
Cpt1a 1434866_x_at 2.87 1.87 2.79 **
1438156_x_at 2.60
Cpt2 1416772_at 1.39 1.44
Ela2 1448281_a_at 2.04 4.26
Ela3b 1415884_at 2,64 7.89
1435611_x_at 4,20
1415883_a_at 4,38
1437326_x_at 4,72
1435012_x_at 5,17
H2-Q10 1425137_a_at -8.22 -2.39
Hmgcs1 1433443_a_at -1.82 -2.00
1433446_at -1.57
Hmgcs2 1431833_a_at 3.61 3.97
1423858_a_at 4.56
Hsd3b2/6 1460232_s_at 2.50 n.d. 1.91 *
Hsd3b3 1427377_x_at 2.00
Mod1 1416632_at 2.16 2.60
1430307_a_at 2.13
Pck1 1423439_at 2.17 2.21
1439617_s_at 2.46
Pdk4 1417273_at 3.01 n.d. 3.24 *
Sqle 1415993_at -2.14 -2.35 -1.55 *
Genes are sorted alphabetically. In several cases gene family members were included for validation, although they did not show differential 
microarray gene expression. Data is represented by ratio of EPA&DHA/control diet. For qRT-PCR, data shown is obtained using a pool of samples 
(pool), and/or individual samples (EPA/DHA: n = 11, control diet: n = 10) and the mean ratio was calculated. a this probeset is non-expressed 
(absent) in control diet; ratio is 6.9; b n.c.: not changed. c n.d.: not analyzed; statistical significance was calculated using Student's t-test: * p < 0.05, ** 
p < 0.01.BMC Genomics 2009, 10:110 http://www.biomedcentral.com/1471-2164/10/110
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marine origin. The small intestine mediates the entry of
nutritional lipids and is one of the main sites of β-oxida-
tion [32-34]. Therefore, an increase in lipid oxidation in
the intestine may exert a hypolipidemic effect, i.e. one of
the most pronounced effects of EPA and DHA in mam-
mals (reviewed in [1,3]). This effect of EPA&DHA in the
Gene expression in small intestine Figure 1
Gene expression in small intestine. Quantatative real-time PCR (qRT-PCR) was used to determine normalized gene 
expression levels in small intestine of individual wildtype mice that received the control diet (n = 10, white bars) or EPA&DHA 
diet (n = 11, black bars). Gene expression levels were normalized using calnexin and averaged per group; the mean expression 
level of the control group was arbitrarily set at 1. Bars are presented as mean ± standard error. Genes shown (with the mean 
ratio between the groups shown in parenthesis) are a Acaa1 (2.52), b Acacb (3.91), c Cpt1a (2.79), d Hsd3b (1.91), e Pdk4 
(3.24), f Sqle (-1.55). Statistical significance was analyzed using Student's t-test: * p < 0.05, ** p < 0.01. AU, arbitrary units.BMC Genomics 2009, 10:110 http://www.biomedcentral.com/1471-2164/10/110
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intestine is surprisingly similar to the enhanced lipid oxi-
dation induced by diacylglycerols versus triacylglycerols
[18,19]. These two types of treatments both have rela-
tively little effects in liver and muscle ([20]; own unpub-
lished data). In contrast, in white adipose tissue, intake of
EPA&DHA induced genes of fatty acid oxidation, as well
as quite specifically, mitochondrial biogenesis [8]. Taken
together, EPA and DHA orchestrate gene expression adap-
tations in many tissues, including the intestine.
Recent studies addressing the gene expression changes of
intestinal tissue upon fish oil or fatty acids, focussed on
barrier genes only [16] or a focussed limited number of
genes by qRT-PCR [34], while here a whole genome
approach was used. This allows for detection of changes
not only in the most likely pathways, but also in pathways
not foreseen. Our study supports the findings by Mori et
al. [34] for the majority of their selected genes analyzed
(Cpt1a, Mod1, Pdk4, Hmgcs2, Cyp4a10, and Acadm), as
well as for barrier gene expression ([16], data not shown).
Unexpectedly, we observed intestinal downregulation of
cholesterol biosynthesis due to EPA&DHA, although this
is in agreement with a similar effect observed in murine
livers after tuna fish oil feeding [11]. In addition, this
might coincide with a possible increase in cholesterol
absorption as observed from ScarB1,  Cd36,  Abca1  and
Ela3B  gene expression, even with identical cholesterol
content of the diets. Intracellular homeostasis may
decrease cholesterol biosynthesis to counteract increased
influx. Maintenance of homeostasis is supported by non
differential expression of Soat2/ACAT, involved in choles-
terol esterification and of other genes in cholesterol
metabolism (HMG-CoA reductase, Npc1l1, Mttp, Abcg5,
Abcg8, Nr1h2 (LXR ) and Nr1h3 (LXR )). The intestinal
lack of regulation of Srebf1/SREBP further strengthen the
observations that PUFA regulation of SREBP that accounts
for PUFA-mediated suppression of gene expression seems
to be liver-specific [13]. Furthermore, of the regulatory
machine known to be induced by DHA and EPA (PPARs,
LXRs, HNF4A, and SREBPs), only PPARα showed differ-
ential expression in murine small intestine. This is further
supported by our promoter-analysis of the differentially
regulated genes, which showed PPARα as the major tran-
scription factor involved.
Moreover, most if not all tissues analysed thus far show an
increased energy metabolism upon n-3 FFA, and our
results support the notion of the beneficial effects of fish
oils independent of its n-3 effect.
Genes engaged in lipid oxidation and ketogenesis are in
general upregulated in small intestine [35], liver [20], and
skeletal muscle [36] by an increase in dietary fat content.
When activated in the muscle, ketogenesis marks a meta-
bolic disconnection between β-oxidation and tricarboxy-
lic acid cycle and could lead to insulin resistance [36]. In
our study however, we compared diets with equal fat con-
tent in control and intervention groups, which only dif-
fered in their fatty acid composition. This implies that
marine PUFAs specifically induce lipid catabolism in
intestine. Furthermore, in comparison with another high
fat Western diet [35], we observed similar (up or down)
gene expression regulation by EPA&DHA diet (e.g.
Angplt4, Gsn, and Smpdl3), as well as an inverse regulation
(e.g. ApoC2 and H2Q10 are upregulated by a high-fat diet
Gene expression in colon Figure 2
Gene expression in colon. qRT-PCR was used to deter-
mine normalized gene expression levels in colon of individual 
wildtype mice that received the control diet (n = 12, white 
bars) or EPA&DHA diet (n = 11, black bars). Gene expres-
sion levels were normalized using calnexin and averaged per 
group; the mean expression level of the control group was 
arbitrarily set at 1. Bars are presented as mean ± standard 
error. Genes and fold changes in parenthesis shown are a 
Acaa1 (1.29), b Cpt1a (1.37), c Sqle (1.08). All changes are 
non-significant (p > 0.2, Student's t-test). AU, arbitrary units.
Dose-dependent intestinal gene expression and fatty acid  beta oxidation Figure 3
Dose-dependent intestinal gene expression and fatty 
acid beta oxidation. In a second animal experiment, intes-
tinal gene expression analysis was used to confirm and bio-
logically validate observations in a dose-dependent manner. 
Gene expression analysis was performed using qRT-PCR of 
small intestinal samples of individual wildtype mice that 
received the control diet (n = 9, white bars), EPA&DHA diet 
(n = 9, black bars), and intermediate levels of dietary 
EPA&DHA (n = 9, hatched bars). The triangle shows increas-
ing dietary EPA&DHA content. Gene expression levels were 
normalized using calnexin and averaged per group; the mean 
expression level of the control group was arbitrarily set at 1. 
Bars represent mean ± standard error. Genes shown are a: 
Cpt1a, and b: Acacb. Functional fatty acid beta oxidation was 
used for biological validation (c). Intestinal tissue fatty acid 
beta oxidation (n = 7–9) is shown for mice that received con-
trol diet (white bars), EPA&DHA diet (black bars), and inter-
mediate levels of dietary EPA-DHA (hatched bars). The 
triangle shows increasing dietary EPA&DHA content. Statisti-
cal significance was analyzed using one-way ANOVA and 
Tuckey's post hoc tests: * p < 0.05, *** p < 0.01. AU, arbi-
trary units.BMC Genomics 2009, 10:110 http://www.biomedcentral.com/1471-2164/10/110
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[35], but downregulated by EPA&DHA). Differences
might be explained by the fatty acid content in the diets
used.
Despite decreased adiposity due to EPA&DHA in the diet,
these fatty acids have not affected total energy intake
[8,22], and also content of lipids in faeces was unaffected
[22]. This strongly suggests a higher energy expenditure in
the animals exposed to EPA&DHA. The results presented
here indicate that one of the organs that physiologically
contribute to increased oxidation of fatty acids is the small
intestine.
Conclusion
In conclusion, we present data showing the involvement
of small intestine in the complex changes of lipid metab-
olism exerted by long term dietary intake of EPA and DHA
by gene expression analysis and functional ex-vivo beta
oxidation analysis. Furthermore, we show that these
effects are regulated in a dose-dependent manner. In view
of its large contribution to overall energy metabolism,
modulation of gene expression and metabolism in the
intestine by dietary lipids, and especially long-chain n-3
PUFA of marine origin, represents a promising target for
the prevention of obesity and associated co-morbidities.
Methods
Animals and diets
In the first experiment, male 4-month-old C57BL/6J mice
were maintained for 4 weeks on semisynthetic high-fat
(20% wt/wt) diets differing in the composition of n-3
PUFA. These mice were already used in our previous study
[8]. Two isocaloric diets [8,22] were used (n = 12): control
sHFf diet which contained flax-seed oil (rich in ALA) as
the only lipid source, or the sHFf-F2 diet, which had the
same composition except that 44% of the lipids were
replaced by a n-3 PUFA concentrate containing 6% EPA
and 51% DHA (EPAX 1050TG; EPAX AS, Lysaker, Nor-
way). This diet is denoted as EPA&DHA throughout the
study. At the end of the experiment, mice were killed by
cervical dislocation and small intestine from 3 cm under
the stomach to caecum was isolated and cut lengthwise.
The intestine was washed in 154 mM KCl and scraped.
The epithelial cells were collected, frozen in liquid nitro-
gen and stored at -80°C. This procedure was also per-
formed for 5 cm of colon.
In the second experiment, subgroups (n = 9) of male 4-
month-old C57BL/6J mice were fed either (i) control
obesity-promoting high-fat (35% lipids wt/wt; cHF) diet
derived from standard chow diet based on corn oil, or (ii)
and (iii) cHF diet with 15 and 44% of lipids, respectively,
replaced by EPAX 1050TG (cHF-F1 and cHF-F2, respec-
tively; see [22]). After 6 weeks, intestinal tissue was iso-
lated for fatty acid beta oxidation and gene expression
analysis by quantitative RT-PCR (qRT-PCR) only. Macro-
nutrient composition, energy density, and fatty acid com-
position of dietary lipids of all the diets used in this study
is well characterised [22]. The experiments were con-
ducted under the guidelines for the use and care of labo-
ratory animals of the Institute of Physiology, Academy of
Sciences of the Czech Republic.
RNA isolation
Extraction of total RNA was performed with the use of
TRIzol (Invitrogen, Breda, The Netherlands). RNeasy col-
umns (Qiagen, Venlo, The Netherlands) were used to
purify the RNA. Quantitative and qualitative measures
were performed using Nanodrop ND-1000 Spectropho-
tometer (NanoDrop Technologies, Delaware, USA). For
the first animal experiment, four samples did not pass
quality thresholds and were excluded from further analy-
ses (two control small intestine samples and one
EPA&DHA small intestine sample and one EPA&DHA
colon sample). The remaining RNA samples were pooled
per tissue per diet and integrity was analyzed after keeping
the samples for 1 hour at 37°C using an Agilent bioana-
lyzer (Agilent Technologies, Amstelveen, The Nether-
lands) with a RNA 6000 Nano LabChip kit, according to
the manufacturer's instructions. The two pooled colon
samples were not used further due to their apparent par-
tial degradation (RNA Integrity Number (RIN) < 7.0). All
individual RNA samples from the second animal experi-
ment passed quality control criteria, and were used for
subsequent qRT-PCR analysis.
Array hybridization and scanning
The pools of small intestine RNA samples (control (n =
10) and EPA&DHA (n = 11)) were hybridized on separate
Affymetrix MOE430_2 GeneChip mouse arrays (Santa
Clara, CA, USA). This array contains 45,102 probesets,
detecting over 39,000 transcripts that represent 16,579
unique genes. Detailed methods for labelling and subse-
quent hybridizations to the arrays are described in the
eukaryotic section in the GeneChip Expression Analysis
Technical Manual Rev. 3 from Affymetrix, and are availa-
ble upon request. Arrays were scanned on a GeneChip
Scanner 3000 (Affymetrix).
Microarray data analysis
Quality of the data was assessed on diagnostic plots gen-
erated from the raw, non-processed data, as described
[37]. All arrays passed these strict criteria and were
included in the analyses.
The Affymetrix default algorithm (MAS 5.0) was used to
summarize data and significance of observed gene expres-
sion changes (present/absent call per probeset per array,
fold change (FC) between normalized arrays, and its sig-
nificance by the p-value). In total, 24270 probesets (54%)BMC Genomics 2009, 10:110 http://www.biomedcentral.com/1471-2164/10/110
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showed expression at least in either one of the arrays. Sig-
nificant differentially expressed probesets were identified
by direct comparison between the two dietary groups for
all probesets called present on both arrays. Probesets that
satisfied the general Affymetrix criterion of t-test probabil-
ity < 0.27% (p-value < 0.0027) were considered to be sig-
nificantly regulated, and these were further investigated.
Probesets were annotated using information provided by
Affymetrix (release of July 12th, 2006) and all gene sym-
bols are presented throughout the article according to
Mouse Genome Informatics [38].
Pathway analysis, including ranking, was done using Met-
acore (GeneGo, St. Joseph, MI, USA). The data of func-
tionally annotated genes only were analyzed in two
subsets. In order to successfully rank the most prominent
differentially regulated pathway(s), a large set of genes
was analyzed. In this way, those pathways showing a high
number of significant regulated genes, given the (high)
number of genes expressed within the pathway, will rank
highest. The first subset comprised those genes of which
expression was present in both dietary conditions. Path-
way analysis was done using a cut-off of absolute FC ≥ 1.5
or ≥ 2.0 and the p-value per gene as provided by MAS5.0,
in order to increase detection of biological relevant regu-
lated pathways. The second subset comprised probesets
expressed in only one dietary group, and therefore absent
in the other (FC ≥ 2.0). The given FCs as generated by MAS
5.0 were used, although in view of the absence of expres-
sion under one dietary condition these may not be relia-
ble, hence the choice of separate analysis. Array data have
been submitted to the Gene Expression Omnibus, acces-
sion number GSE11936.
Promoter analysis to identify transcription factor 
regulation
All differentially regulated probesets, as shown in Table 1,
were analyzed using Genomatix BiblioSphere Pathway
Edition software, without any pre-selection in up- or
down-regulation. Unique genes were identified and those
genes plus gene-gene interactions were filtered [39] for
organ-specificity using MeSH [Medical Subject Heading]
"Digestive System" [A03]. This resulted in a set of 50
unique input genes. Promoter regions of around 650 bp
upstream of transcription start site per gene were analysed
for known transcription factor binding sites (TFBS) com-
bined with prior knowledge in literature. Criteria for this
analysis were: only direct interactions were considered, a
minimum of 3 published articles should describe the
functional interaction (so called "function word level
B2"), and for inclusion of a transcription factor (TF)
showing TF-gene interaction, the additional criterion of at
least two different input genes having this specific TFBS
was compulsory. In this way we analyzed specifically only
TF-gene interactions relevant for the gastrointestinal tract.
Quantitative real time PCR
qRT-PCR was performed according to Van Schothorst et
al. [40]. Briefly, 1 μg of total RNA was used for cDNA syn-
thesis. Primers were designed using Beacon Designer (Bio-
soft International, Palo Alto, USA) and ordered by
Biolegio (Malden, The Netherlands). Gene symbols,
names, accession numbers and primer sequences are
listed in an additional file [see Additional file 5]. Analysis
of the reaction efficiency [41] was performed with a dilu-
tion series of pooled cDNAs serving as standard curve.
Briefly, after a 3 minute denaturation at 94°C, 40 cycles of
15 seconds at 94°C and 30 seconds at 59°C, were fol-
lowed by a melting curve gradient. Calnexin (Canx) and
hypoxanthine guanine phosphoribosyl transferase 1
(Hprt1) were used as reference genes based on least varia-
tion observed in microarray data analysis. Canx showed
most stable expression and was used and shown in all
cases. Endorsable data were obtained using Hprt1. Ct-val-
ues of the two pools of dietary groups were measured for
17 genes in triplo and averaged, followed by calculation
of the relative gene expression using the 2-ΔΔCT method
[42].
Relative target gene expression was measured in more
detail using individual samples for the genes Cpt1a,
Acaa1a, Sqle, Acacb, Pdk4 and Hsd3b, of which the latter
three were not analysed using pooled RNA samples. Sam-
ples were run in duplicate, averaged, and relative gene
expression was calculated using the standard curve
method. qRT-PCR analyses for the second animal experi-
ment were performed using individual RNA samples for
target genes Cpt1a and Acacb, as described above.
All values are presented as mean ± SE. In case of only 2
groups (first experiment), differences between groups
were analyzed using Student t-tests with two-tailed, une-
qual variances and significance expressed at p < 0.05, or
lower as indicated, while differences between three groups
(second experiment) were analysed using one-way
ANOVA and Tuckey's posthoc tests and significance
expressed at p < 0.05, or lower as indicated.
Fatty acid beta oxidation
Intestinal fatty acid beta oxidation was measured as pub-
lished [43]. Briefly, samples were incubated in Krebs-
Ringer bicarbonate buffer with [14C(U)]-palmitate, 14CO2
was trapped in hyamine hydroxide, quantified by liquid
scintillation counting, and oxidation rate was normalized
to tissue DNA content [44]. All data are presented as mean
± SE. Differences between groups were analyzed using
one-way ANOVA and Tuckey's post hoc tests and consid-
ered statistically significance at p < 0.05.
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